Diabetology International

, Volume 10, Issue 3, pp 153–179 | Cite as

Diabetes care providers’ manual for disaster diabetes care

  • Jo SatohEmail author
  • Koichi Yokono
  • Rie Ando
  • Toshinari Asakura
  • Kazuhiko Hanzawa
  • Yasushi Ishigaki
  • Takashi Kadowaki
  • Masato Kasuga
  • Hideki Katagiri
  • Yasuhisa Kato
  • Koreyuki Kurosawa
  • Masanobu Miura
  • Jiro Nakamura
  • Koichi Nishitsuka
  • Susumu Ogawa
  • Tomoko Okamoto
  • Sadanori Sakuma
  • Shigeru Sakurai
  • Hiroaki Satoh
  • Hidetoshi Shimauchi
  • Hiroaki Shimokawa
  • Wataru Shoji
  • Takashi Sugiyama
  • Akira Suwabe
  • Masahiro Tachi
  • Kazuma Takahashi
  • Susumu Takahashi
  • Yasuo Terayama
  • Hiroaki Tomita
  • Yoko Tsuchiya
  • Hironori Waki
  • Tsuyoshi Watanabe
  • Kazuaki Yahata
  • Hidetoshi Yamashita
Report of the Committee


To ensure that experiences and lessons learned from the unprecedented 2011 Great East Japan Earthquake are used to improve future disaster planning, the Japan Diabetes Society (JDS) launched the “Research and Survey Committee for Establishing Disaster Diabetes Care Systems Based on Relevant Findings from the Great East Japan Earthquake” under the supervision of the Chairman of the JDS. The Committee conducted a questionnaire survey among patients with diabetes, physicians, disaster medical assistance teams (DMATs), nurses, pharmacists, and nutritionists in disaster areas about the events they saw happening, the situations they found difficult to handle, and the needs that they felt required to be met during the 2011 Great East Japan Earthquake. A total of 3,481 completed questionnaires were received. Based on these and other experiences and lessons reported following the 2011 Great East Japan Earthquake and the 2004 Niigata-Chuetsu Earthquakes, the current “Manual for Disaster Diabetes Care” has been developed by the members of the Committee and other invited authors from relevant specialties. To our knowledge, the current Manual is the world’s first to focus on emergency diabetes care, with this digest English version translated from the Japanese original. It is sincerely hoped that patients with diabetes and healthcare providers around the world will find this manual helpful in promoting disaster preparedness and implementing disaster relief.


Diabetes Disaster Manual Patient care Earthquake 



Acute coronary syndrome


Acute kidney injury


Angina pectoris


Acute stress disorder


Calcium channel blocker


Certified Diabetes Educator of Japan


Cardiac failure


Cerebral infarction


Continuous subcutaneous insulin infusion


Cardiovascular disease


Diabetes medical assistance team


Dipeptidyl peptidase-4


Deep vein thrombosis


Electronic medical records


Glucagon-like peptide-1


Ischemic heart disease


Information technology


Japan Medical Association team


Medical aid stations


Myocardial infarction


Neovascular glaucoma


Panic disorder


Pulmonary embolism


The prothrombin time/international normalized ratio


Posttraumatic stress disorder


The renin–angiotensin system


Retinal detachment


Standard deviation


Sodium glucose co-transporter 2


Social network services






α-Glucosidase inhibitor


Compliance with ethical standards

Conflict of interest statement

Jo Satoh received honoraria from Boehringer Ingelheim, Eli Lilly and Company, MSD, Ono pharmaceutical Co., Ltd., Sanofi, and Sumitomo Dainippon Pharma Co., Ltd. Toshinari Asakura received honoraria from Novo Nordisk. TA also received research funding from Eli Lilly Japan. Kazuhiko Hanzawa received honoraria from Daiichi Sankyo Co. Yasushi Ishigaki received honoraria from MSD Ltd., Sanofi Ltd., Bayer Yakuhin Ltd., Takeda pharmaceutical Co., Novo Nordisk Pharma Ltd., Novartis Pharma Ltd., Ono pharmaceutical company, Kowa pharmaceutical Co., Ltd. YI also received subsidies/donations from MSD Ltd., Ono pharmaceutical company. Takashi Kadowaki received honoraria from MSD Corporation, Daiichi Sankyo Co., Ltd., Takeda Pharmaceutical Co., Ltd., Mitsubishi Tanabe Pharma Corporation, Kowa Pharmaceutical Co., Ltd., Astellas Pharma Inc., Ono Pharmaceutical Co., Ltd., AstraZeneca K. K., Sumitomo Dainippon Pharma Co., Ltd., Sanofi K. K., Eli Lilly Japan K. K., Nippon Boehringer Ingelheim Co. Ltd., Sanwa Kagaku Kenkyusho Co., Ltd., Kyowa Hakko Kirin Co., Ltd., and Taisho Pharmaceutical Co., Ltd. TK also received research funding from MSD Corporation, Daiichi Sankyo Co., Ltd., Novo Nordisk Pharma Ltd., Sanofi K. K., and Takeda Pharmaceutical Co., Ltd. TK belongs to endowed departments by Takeda Pharmaceutical Co., Ltd., TERUMO Corporation, MSD Corporation, Novo Nordisk Pharma Ltd., and Nippon Boehringer Ingelheim Co. Ltd. Hideki Katagiri received honoraria from Astellas Pharma Inc., Daiichi-Sankyo, Taisho Toyama Pharmaceutical Co., Ltd., Mitsubishi Tanabe Pharma Co., Boehringer Ingelheim, MSD K.K., and Novartis Pharma. HK also received subsidies/donations from Astellas Pharma Inc., Novo Nordisk Pharma Ltd., Takeda Pharmaceutical Company Ltd., Sanofi K.K., Daiichi-Sankyo, Eli Lilly Japan K.K., Taisho Toyama Pharmaceutical Co., Ono Pharmaceutical Co., Ltd., Mitsubishi Tanabe Pharma Co., MSD K.K., and Novartis Pharma. Jiro Nakamura received honoraria from Astellas Pharma Inc., AstraZeneca K.K., MSD KK., Ono Pharmaceu. Co., Ltd., Daiichi Sankyo Co., Ltd., Kowa Pharmaceu, Co., Ltd., Sanofi K.K., Takeda Pharmaceu. Co., Ltd., Mitsubishi Tanabe Pharma Corp., Terumo Co., Boehringer Ingelheim Japan Co., Ltd., Eli Lilly Japan K.K., Novartis Pharma K.K., and Novo Nordisk Pharma Ltd. JN also received research funding from Kissei Pharmaceu. Co., Ltd., Boehringer Ingelheim Japan Co., Ltd., and EPS Co., Ltd. JN also received subsidies/donations from Astellas Pharma Inc., MSD K.K., Ono Pharmaceu. Co., Ltd., Sanofi K.K., Daiichi Sankyo Co., Ltd., Taisho Toyama Pharmaceu. Co., Ltd., Sumitomo Dainippon Pharma Co., Ltd., Takeda Pharmaceu. Co., Ltd., Eli Lilly Japan K.K., Japan Tobacco Inc., Novartis Pharma K.K., and Novo Nordisk Pharma Ltd. Shigeru Sakurai received subsidies/donations from Philips-Respironics Co., Ltd. Hiroaki Tomita received subsidies/donations from Kodama Hospital and Medical Corporation Association Zao-kai. Hironori Waki received subsidies/donations from Sanofi K.K. and Novo Nordisk Pharma Ltd. HW belongs to endowed departments by MSD K.K., Novo Nordisk Pharma Ltd., and Nippon Boehringer Ingelheim Co. Ltd. Koichi Yokono, Rie Ando, Masato Kasuga, Yasuhisa Kato, Koreyuki Kurosawa, Masanobu Miura, Koichi Nishitsuka, Susumu Ogawa, Tomoko Okamoto, Sadanori Sakuma, Hiroaki Satoh, Hidetoshi Shimauchi, Hiroaki Shimokawa, Wataru Shoji, Takashi Sugiyama, Akira Suwabe, Masahiro Tachi, Kazuma Takahashi, Susumu Takahashi, Yasuo Terayama, Yoko Tsuchiya, Tsuyoshi Watanabe, Kazuaki Yahata, Hidetoshi Yamashita declare that they have no conflict of interest.

Ethical approval

This article does not contain any studies with human or animal subjects performed by any of the authors.


  1. 1.
    Kadowaki T. Condolences for the victims of the Tohoku Pacific Ocean Earthquake and report of the Japan Diabetes Society disaster relief activities (in Japanese). Accessed 22 March 2019.
  2. 2.
    Report Timely. Diabetes treatment in times of disaster. J Jpn Diabetes Soc. 2011;54:657–74 (in Japanese).Google Scholar
  3. 3.
    Report Timely. Comprehensive team medicine in times of disaster. J Jpn Diabetes Soc. 2011;54:713–31 (in Japanese).Google Scholar
  4. 4.
    Japan Diabetes Society. Report of questionnaire survey results. Research and surveys for establishing disaster diabetes care systems based on relevant findings from the Great East Japan Earthquake. The Japan Diabetes Society 2012 (in Japanese).Google Scholar
  5. 5.
    Yamamoto Y. Preparing for future Tokai, Tonankai, and Nankai earthquakes in anticipation of unprecedented, extremely broad-based earthquakes. Jpn J Diabetic Caring. 2008;5:82–5 (in Japanese).Google Scholar
  6. 6.
    Nakahara I, et al. Present state of risk management in insulin treatment for type 1 diabetic patients and its renovation. J Jpn Diabetes Soc. 2004;47:395–7 (in Japanese).Google Scholar
  7. 7.
    Kumasaka Y. Diabetes medical care in the community at the time of disaster. J Jpn Diabetes Soc. 2011;54:668–9 (in Japanese).Google Scholar
  8. 8.
    Asakura T, et al. About the influence of air mixing on concentration and precision of the injection of the injection device: the negative influence of storing a device with the needle attached. J Jpn Diabetes Soc. 2007;50:877–82 (in Japanese).Google Scholar
  9. 9.
    Asakura T, et al. Alternation of insulin preparations and insulin injection devices by freezing and thawing for guiding diabetic patients proper insulin therapy. J Jpn Diabetes Soc. 2003;46:767–73 (in Japanese).Google Scholar
  10. 10.
    Hanzawa K. On the risk of pulmonary/vein thromboembolism in individuals staying in vehicles after the Niigata-Chuetsu Earthquakes: echocardiographic findings from those staying in vehicles. Ther Res. 2005;26:1207–12 (in Japanese).Google Scholar
  11. 11.
    Hanzawa K, et al. A medical report of the mid Niigata Prefecture Earthquake 2004: results of ultrasonography in lower leg. Niigata Med J. 2006;120:15–20 (in Japanese).Google Scholar
  12. 12.
    Sakuma M, et al. Acute pulmonary embolism after an earthquake in Japan. Semin Thromb Hemost. 2006;32:857–60.CrossRefGoogle Scholar
  13. 13.
    Shibata M, et al. Deep venous thrombosis among disaster shelter inhabitants following the March 2011 earthquake and tsunami in Japan: a descriptive study. Phlebology. 2014;29:257–66.CrossRefGoogle Scholar
  14. 14.
    Simpson K. Shelter deaths from pulmonary embolism. Lancet. 1940;2:744.CrossRefGoogle Scholar
  15. 15.
    Hanzawa K. Frequency of DVT after the Niigata-Chuetsu earthquakes. Ther Res. 2008;29:641–3 (in Japanese).Google Scholar
  16. 16.
    Hanzawa K, et al. Frequency of DVT after the Iwate-Miyagi Nairiku (Inland) Earthquake: relationship with refugee shelter environments. Ther Res. 2009;30:572–4 (in Japanese).Google Scholar
  17. 17.
    Hanzawa K. Frequency of DVT and hypertension among Fukushima refugees living in refugee shelters outside Fukushima Prefecture: Relationship with refugee shelter environments. Thromb Circ. 2012;20:53–61 (in Japanese).Google Scholar
  18. 18.
    Ueda S, et al. High prevalence of deep vein thrombosis in Tsunami-flooded shelters established after the Great East-Japan Earthquake. Tohoku J Exp Med. 2012;227:199–202.CrossRefGoogle Scholar
  19. 19.
    Shibata S, et al. Team Kurihara—venous thromboembolism prevention activities. Heart. 2010;42:473–80 (in Japanese).Google Scholar
  20. 20.
    Fuse I, et al. Guidelines for diagnosis and treatment of deep vein thrombosis (DVT) in residents in areas affected by the Niigata-Chuetsu Earthquake. J Niigata Med Assoc. 2006;675:2–12 (in Japanese).Google Scholar
  21. 21.
    Ministry of Health, Labor and Welfare Research Group, Japanese Society for Infection Prevention and Control, e Niigata-Chuetsu Earthquake. e shelter environments. g in vehicles. icle. (in Japanese). Accessed 22 March 2019.
  22. 22.
    Aoki T, et al. The Great East Japan earthquake disaster and cardiovascular diseases. Eur Heart J. 2012;33:2796–803.CrossRefGoogle Scholar
  23. 23.
    Minami J, et al. Effect of the Hanshin-Awaji earthquake on home blood pressure in patients with essential hypertension. Am J Hypertens. 1997;10:222–5.CrossRefGoogle Scholar
  24. 24.
    Kamoi K, et al. Effect of the 2004 Mid-Niigata Prefecture Earthquake on home blood pressure measurement in the morning in type 2 diabetic patients. Clin Exp Hypertens. 2006;28:719–29.CrossRefGoogle Scholar
  25. 25.
    Tanaka K, et al. The great East Japan earthquake: blood pressure control in patients with chronic kidney disease. Am J Hypertens. 2012;25:951–4.CrossRefGoogle Scholar
  26. 26.
    Kario K, et al. Factors associated with the occurrence and magnitude of earthquake-induced increases in blood pressure. Am J Med. 2001;111:379–84.CrossRefGoogle Scholar
  27. 27.
    Tanaka K, et al. Home blood pressure control after the Great East Japan Earthquake in patients on chronic hemodialysis. Ther Apher Dial. 2014;18:149–54.CrossRefGoogle Scholar
  28. 28.
    Giorgini P et al. Long term blood pressure change induced by the 2009 L’aquila earthquake. Assessment by 24 h ambulatory monitoring. Hypertens Res. 2013;36:795–798.Google Scholar
  29. 29.
    Tanaka K, et al. Aftercare for the prevention of a secondary health disaster in survivors of major earthquakes. Hypertens Res. 2013;36:759–61.CrossRefGoogle Scholar
  30. 30.
    Inui A, et al. Effect of the Kobe earthquake on stress and glycemic control in patients with diabetes mellitus. Arch Int Med. 1998;158:274–8.CrossRefGoogle Scholar
  31. 31.
    Fujihara K, et al. Impact of psychological stress caused by the Great East Japan Earthquake on glycemic control in patients with diabetes. Exp Clin Endocrinol Diabetes. 2012;120:560–3.CrossRefGoogle Scholar

Copyright information

© The Japan Diabetes Society 2019

Authors and Affiliations

  • Jo Satoh
    • 1
    Email author
  • Koichi Yokono
    • 2
  • Rie Ando
    • 3
  • Toshinari Asakura
    • 4
  • Kazuhiko Hanzawa
    • 5
  • Yasushi Ishigaki
    • 6
  • Takashi Kadowaki
    • 7
    • 8
  • Masato Kasuga
    • 9
  • Hideki Katagiri
    • 10
  • Yasuhisa Kato
    • 11
  • Koreyuki Kurosawa
    • 12
  • Masanobu Miura
    • 13
  • Jiro Nakamura
    • 14
  • Koichi Nishitsuka
    • 15
  • Susumu Ogawa
    • 16
  • Tomoko Okamoto
    • 17
  • Sadanori Sakuma
    • 18
  • Shigeru Sakurai
    • 19
  • Hiroaki Satoh
    • 20
  • Hidetoshi Shimauchi
    • 21
  • Hiroaki Shimokawa
    • 13
  • Wataru Shoji
    • 22
  • Takashi Sugiyama
    • 23
  • Akira Suwabe
    • 24
  • Masahiro Tachi
    • 12
  • Kazuma Takahashi
    • 25
  • Susumu Takahashi
    • 26
  • Yasuo Terayama
    • 27
  • Hiroaki Tomita
    • 21
  • Yoko Tsuchiya
    • 28
  • Hironori Waki
    • 29
  • Tsuyoshi Watanabe
    • 30
  • Kazuaki Yahata
    • 31
  • Hidetoshi Yamashita
    • 15
  1. 1.Tohoku Medical and Pharmaceutical UniversityWakabayashi HospitalSendaiJapan
  2. 2.Kita-Harima Medical CenterOnoJapan
  3. 3.Kanagawa University of Human ServicesYokosukaJapan
  4. 4.Faculty of Pharmaceutical SciencesNiigata University of Pharmacy and Applied Life SciencesNiigataJapan
  5. 5.Advanced Treatment and Prevention for Vascular Disease and EmbolismNiigata University Graduate School of Medicine and Dental SciencesNiigataJapan
  6. 6.Division of Diabetes, Metabolism and Endocrinology, Department of Internal MedicineIwate Medical UniversityMoriokaJapan
  7. 7.Department of Prevention of Diabetes and Lifestyle-Related Diseases, Graduate School of MedicineThe University of TokyoTokyoJapan
  8. 8.Department of Metabolism and NutritionMizonokuchi Hospital, Faculty of Medicine, Teikyo UniversityTokyoJapan
  9. 9.The Institute for Adult Diseases, Asahi Life FoundationTokyoJapan
  10. 10.Department of Metabolism and DiabetesTohoku University Graduate School of MedicineSendaiJapan
  11. 11.Sakae-Katou ClinicNagoyaJapan
  12. 12.Department of Plastic and Reconstructive Surgery, Graduate School of MedicineTohoku UniversitySendaiJapan
  13. 13.Department of Cardiovascular MedicineTohoku University Graduate School of MedicineSendaiJapan
  14. 14.Division of Diabetes, Department of Internal MedicineAichi Medical University, School of MedicineNagakuteJapan
  15. 15.Department of OphthalmologyYamagata University Faculty of MedicineYamagataJapan
  16. 16.Division of Nephrology, Endocrinology and Vascular MedicineTohoku University HospitalSendaiJapan
  17. 17.Tohoku University HospitalSendaiJapan
  18. 18.Hirosaka Cardiology Medical ClinicKoriyamaJapan
  19. 19.Division of Infection Control, Department of Medical SafetyIwate Medical University HospitalMoriokaJapan
  20. 20.Department of Metabolism and EndocrinologyJuntendo UniversityTokyoJapan
  21. 21.Tohoku UniversitySendaiJapan
  22. 22.Department of Preventive Psychiatry, Graduate School of MedicineTohoku UniversitySendaiJapan
  23. 23.Department of Obstetrics and GynecologyEhime University Graduate School of MedicineToonJapan
  24. 24.Department of Laboratory MedicineIwate Medical University School of MedicineMoriokaJapan
  25. 25.Iwate Prefectural UniversityTakizawaJapan
  26. 26.Nakatsugawa HospitalMoriokaJapan
  27. 27.Division of Neurology and Gerontology, Department of Internal Medicine, School of MedicineIwate Medical UniversityMoriokaJapan
  28. 28.Hirosaki Gakuin UniversityHirosakiJapan
  29. 29.Department of Diabetes and Metabolic Diseases, Graduate School of MedicineThe University of TokyoTokyoJapan
  30. 30.Japan Organization of Occupational Health and Safety, Fukushima Rosai HospitalIwakiJapan
  31. 31.Nagaoka Chuo HospitalNagaokaJapan

Personalised recommendations